These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 32202476)

  • 21. Making a Difference for Patients with Peripheral Artery Disease by Advocating Together as One.
    Matsumoto AH; Angle JF; Benenati JF; Wiechmann BN; Victoria Marx M; Haskal ZJ
    J Vasc Interv Radiol; 2016 Jul; 27(7):952-3. PubMed ID: 27177751
    [No Abstract]   [Full Text] [Related]  

  • 22. Determinants of procedural success and patency following subintimal angioplasty in patients with TASC C and D femoropopliteal arterial disease.
    Kim SJ; Kim W; Kim JB; Hong MJ; Kang WY; Hwang SH; Kim W
    Circ J; 2010 Sep; 74(9):1959-64. PubMed ID: 20668355
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TASC II and the endovascular management of infrainguinal disease.
    Lyden SP; Smouse HB
    J Endovasc Ther; 2009 Apr; 16(2 Suppl 2):II5-18. PubMed ID: 19624072
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Not Available].
    Gottsäter A; Näslund U
    Lakartidningen; 2018 Feb; 115():. PubMed ID: 29406561
    [No Abstract]   [Full Text] [Related]  

  • 25. Complexity of lower extremity peripheral artery disease reflects the complexity of coronary artery disease.
    Aykan AÇ; Hatem E; Karabay CY; Gül İ; Gökdeniz T; Kalaycıoğlu E; Turan T; Kara F; Arslan AO; Dursun İ; Çetin M; Güler A
    Vascular; 2015 Aug; 23(4):366-73. PubMed ID: 25208901
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The TransAtlantic Inter-Society Consensus (TASC) on the Management of Peripheral Arterial Disease.
    Sacks D
    J Vasc Interv Radiol; 2003 Sep; 14(9 Pt 2):S351. PubMed ID: 14514842
    [No Abstract]   [Full Text] [Related]  

  • 27. Questions and Answers on Diagnosis and Management of Patients with Peripheral Arterial Diseases: A Companion Document of the 2017 ESC Guidelines for the Diagnosis and Treatment of Peripheral Arterial Diseases, in collaboration with the European Society for Vascular Surgery (ESVS).
    Aboyans V; Björck M; Brodmann M; Collet JP; Czerny M; De Carlo M; Naylor AR; Roffi M; Tendera M; Vlachopoulos C; Ricco JB; ; Document Reviewers ; Widimsky P; Kolh P; Dick F; Vega de Ceniga M; Piepoli MF; Sievert H; Sulzenko J; Esc Committee For Practice Guidelines Cpg ; Windecker S; Aboyans V; Agewall S; Barbato E; Bueno H; Coca A; Collet JP; Coman IM; Dean V; Delgado V; Fitzsimons D; Gaemperli O; Hindricks G; Iung B; Jüni P; Katus HA; Knuuti J; Lancellotti P; Leclercq C; McDonagh T; Piepoli MF; Ponikowski P; Richter DJ; Roffi M; Shlyakhto E; Simpson IA; Zamorano JL
    Eur J Vasc Endovasc Surg; 2018 Apr; 55(4):457-464. PubMed ID: 29628287
    [No Abstract]   [Full Text] [Related]  

  • 28. ACC/AHA Versus ESC Guidelines for Diagnosis and Management of Peripheral Artery Disease: JACC Guideline Comparison.
    Kithcart AP; Beckman JA
    J Am Coll Cardiol; 2018 Dec; 72(22):2789-2801. PubMed ID: 30497565
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Commentary on the 2016 Multi-Society Task Force Endoscope Reprocessing Guidelines.
    Hutfless SM; Kalloo AN
    Gastroenterology; 2017 Feb; 152(3):494-496. PubMed ID: 28062202
    [No Abstract]   [Full Text] [Related]  

  • 30. An Update on Methods for Revascularization and Expansion of the TASC Lesion Classification to Include Below-the-Knee Arteries: A Supplement to the Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II).
    ; Jaff MR; White CJ; Hiatt WR; Fowkes GR; Dormandy J; Razavi M; Reekers J; Norgren L
    Vasc Med; 2015 Oct; 20(5):465-78. PubMed ID: 26268268
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Coronary artery disease risk reclassification using an acoustic-based score in view of the new European Society of Cardiology 2019 guidelines on Chronic Coronary Syndromes.
    Schmidt SE; Winther S; Boettcher M
    Int J Cardiovasc Imaging; 2020 Mar; 36(3):383-384. PubMed ID: 31853822
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Specialty Society Clinical Practice Guidelines: Time for Evolution or Revolution?
    Classen DC; Mermel LA
    JAMA; 2015 Sep; 314(9):871-2. PubMed ID: 26237739
    [No Abstract]   [Full Text] [Related]  

  • 33. 24-Month Data from the BRAVISSIMO: A Large-Scale Prospective Registry on Iliac Stenting for TASC A & B and TASC C & D Lesions.
    de Donato G; Bosiers M; Setacci F; Deloose K; Galzerano G; Verbist J; Peeters P; Setacci C
    Ann Vasc Surg; 2015; 29(4):738-50. PubMed ID: 25733220
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ACCF/AHA/ACR/SCAI/SIR/SVM/SVN/SVS 2010 performance measures for adults with peripheral artery disease. A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Performance Measures, the American College of Radiology, the Society for Cardiac Angiography and Interventions, the Society for Interventional Radiology, the Society for Vascular Medicine, the Society for Vascular Nursing, and the Society for Vascular Surgery (Writing Committee to Develop Clinical Performance Measures for Peripheral Artery Disease).
    Olin JW; Allie DE; Belkin M; Bonow RO; Casey DE; Creager MA; Gerber TC; Hirsch AT; Jaff MR; Kaufman JA; Lewis CA; Martin ET; Martin LG; Sheehan P; Stewart KJ; Treat-Jacobson D; White CJ; Zheng ZJ; ; ; ; ; ; ; ; ; Masoudi FA; Bonow RO; DeLong E; Erwin JP; Goff DC; Grady K; Green LA; Heidenreich PA; Jenkins KJ; Loth AR; Peterson ED; Shahian DM
    Vasc Med; 2010 Dec; 15(6):481-512. PubMed ID: 21183653
    [No Abstract]   [Full Text] [Related]  

  • 35. The association of statin therapy with the primary patency of femoral and popliteal artery stents.
    de Grijs D; Teixeira P; Katz S
    J Vasc Surg; 2018 May; 67(5):1472-1479. PubMed ID: 29224939
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Structured Review of Antithrombotic Therapy in Peripheral Artery Disease With a Focus on Revascularization: A TASC (InterSociety Consensus for the Management of Peripheral Artery Disease) Initiative.
    Hess CN; Norgren L; Ansel GM; Capell WH; Fletcher JP; Fowkes FGR; Gottsäter A; Hitos K; Jaff MR; Nordanstig J; Hiatt WR
    Circulation; 2017 Jun; 135(25):2534-2555. PubMed ID: 28630267
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The "Appropriate Use Criteria" for Treatment and Management of Peripheral Artery Disease: The Anesthesiologist Point of View.
    Minkovich LL; Kuiper GJAJM; Djaiani GN
    J Cardiothorac Vasc Anesth; 2019 Aug; 33(8):2118-2122. PubMed ID: 31122845
    [No Abstract]   [Full Text] [Related]  

  • 38. [2011 ESC guidelines on the diagnosis and treatment of peripheral artery diseases].
    Brogneaux C; Sprynger M; Magnée M; Lancellotti P;
    Rev Med Liege; 2012 Nov; 67(11):560-5. PubMed ID: 23346824
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Internal Iliac Artery Disease Management: Still Absent in the Update to TASC II (Inter-Society Consensus for the Management of Peripheral Arterial Disease).
    Mahé G; Kaladji A; Le Faucheur A; Jaquinandi V
    J Endovasc Ther; 2016 Feb; 23(1):233-4. PubMed ID: 26763263
    [No Abstract]   [Full Text] [Related]  

  • 40. The effect of demographic factors and lesion severity on iliac stent patency.
    Roach AN; Larion S; Ahanchi SS; Ammar CP; Brandt CT; Dexter DJ; Panneton JM
    J Vasc Surg; 2015 Sep; 62(3):645-53. PubMed ID: 26094046
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.